Enzalutamide vs Lupron Survival - Prostate Cancer N...

Prostate Cancer Network

5,126 members3,211 posts

Enzalutamide vs Lupron Survival

janebob99 profile image
8 Replies

This shows the main results of the EMBARK trial, comparing Metatasis Free Survival and PSA Recurrence Free Survival for three groups: Enzalutamide only, Lupron only, or combined Enzalutamide + Lupron.

The best survivals were for the combination of Enzalutamide + Lupron.

Enzalutamide is a 2nd generation Anti-Androgen, and Lupron is an anti-testosterone agent.

nejm.org/doi/full/10.1056/N...

Written by
janebob99 profile image
janebob99
To view profiles and participate in discussions please or .
Read more about...
8 Replies
cesanon profile image
cesanon

Thank you.I always look forward to your posts

London441 profile image
London441

it’s a great tandem no doubt. Side effects often much tougher though and definitely not for everyone.

janebob99 profile image
janebob99 in reply to London441

What are the main side effects?

maley2711 profile image
maley2711 in reply to janebob99

From the study..... " The safety profile of enzalutamide was consistent with that shown in previous clinical studies, with no apparent detrimental effect on quality of life." If adding enzalutamide does not add significantly to QOL problems, that is one thing. If the combo actually has a more concerning QOL profile, then, to me, The enzalutamide monotherapy provides just slightly less desirable results than the combo, and I would be tempted to go that route?

Thanks for everything you are providing to folks here!!!

dhccpa profile image
dhccpa

By metastasis-free, does it mean patients had no Mets at beginning of trial, or simply that the Mets they did have didn't grow?

janebob99 profile image
janebob99

Good question. I think "Metatasis-Free" means free from Mets at the beginning of the trial.

The summary of the paper says: "In this phase 3 trial, we enrolled patients with prostate cancer who had high-risk biochemical recurrence with a prostate-specific antigen doubling time of 9 months or less." It doesn't say, but I'm assuming that there are no mets at the beginning. But, the short PSA doubling time (DT) means that they have active prostate cancer growing.

Mgtd profile image
Mgtd

Bob thanks for the info but after looking at your graphs I was left with one burning question.

Are the the results statically significant? Those numbers are pretty close on casual observation except for the Lupron only leg.

janebob99 profile image
janebob99 in reply to Mgtd

Good point.

I went back to the source document to see how many men were studied, and n = 1068 total. So, good statistics.

One main takeaway is that there isn't much difference between Enzulatimide Alone and Enzulatimide + Lupron. The difference is in the noise.

I don't know if the side effects of Enzulatime Alone are less than Lupron. I would think so. Maybe someone could weigh in on this?

Not what you're looking for?

You may also like...

degeralix vs lupron

Hello, Any thoughts on which ADT treatment is better? My husband received his first injection with...

Orgovyx vs. Lupron?

I was approached for a long-term study of Orgovyx. Its possible the cost might be mitigated...

ORGOVYX vs LUPRON

89 year old male Which has less side effects. I suffered significant joint pain in knees with...

Using Enzalutamide, Darolutamide, Apalutamide only.

I've seen a number of posters here and there who say they use one of the "mides" listed above with...

Switch from Lupron/abi to Orgovyx/abi?

As I approaching my third 3 month shot of Lupron I wonder if Orgo might push out my time fence to...